On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.
United by Unique
On World Cancer Day 2025, the theme “United by Unique” highlighted the importance of personalised cancer care. GLIOMATCH supports this by developing a therapy selection platform to advance personalised immunotherapy for glioblastoma and paediatric high-grade glioma.
EU Project Showcase: Collaborating to Advance Cancer Research
Brussels, February 4
To mark the occasion, the European Health and Digital Executive Agency (HaDEA) hosted a project showcase in Brussels, bringing together representatives from EU-funded cancer research initiatives, policymakers, healthcare organisations, and individuals affected by cancer, who shared their personal experiences.
HaDEA manages approximately €1.2 billion in EU funding for cancer-related grants and procurements. The GLIOMATCH project is one of these initiatives funded under the EU’s Cancer Mission (read more about what this entails here).
Highlights from the HaDEA showcase on World Cancer Day 2025
Highlights from the HaDEA showcase on World Cancer Day 2025
As part of the Cancer Mission, GLIOMATCH was among the projects featured at the event.
Dr. Eva Avilla Royo (from EU project management partner, accelopment) was present in Brussels to represent GLIOMATCH and join the roundtable activity on the Cancer Mission’s objectives (see below).
The event underscored the alignment of HaDEA-managed initiatives with key EU cancer policies, including Europe’s Beating Cancer Plan, the EU Cancer Mission, and the European Cancer Imaging Initiative. It featured testimonials from cancer patients, insights from EU representatives, and discussions fostering collaboration among stakeholders.
Mapping the EU Cancer Mission Project Landscape
The EU Cancer Mission includes around 50 funded projects, each addressing one of its four key objectives: understanding, prevention, diagnosis, and quality of life.
Projects contributing to specific objectives—such as GLIOMATCH to “Understanding Cancer”—are grouped into Clusters alongside other projects funded under the same call and running on a similar timeline. GLIOMATCH is one of the six projects united under the “Understanding (Tumour-Host) Interactions” Cluster.
We’ve mapped out the EU Cancer Mission Project Landscape to create an overview of all Cancer Mission projects and thematic Clusters. Explore the interactive visual in our dedicated Cancer Mission area.
For more pictures from our events, visit our photo gallery.
